---
title: "DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291551471.md"
description: "DNA X announced a private placement of 1,346,531 Series B convertible preferred shares for $8.1 million. The transaction includes $5 million in cash and the cancellation of a $3.1 million promissory note. Buyer DNA Holdings Venture, an affiliate of director Scott Walker, acquired the shares. Proceeds are designated for working capital and general corporate purposes."
datetime: "2026-07-02T12:56:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291551471.md)
  - [en](https://longbridge.com/en/news/291551471.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291551471.md)
---

# DNA X announces private placement of 1,346,531 Series B preferred shares for USD 8.1 million

-   DNA X entered a private placement to sell 1,346,531 shares of non-voting Series B Convertible Preferred Stock at USD 6 per share. \* Transaction size USD 8.1 million, comprised of USD 5 million cash, cancellation of USD 3.1 million on a May 2026 convertible promissory note. \* Buyer DNA Holdings Venture, an affiliate of director Scott Walker, holds more than 5% of the outstanding stock. \* Series B converts automatically to common stock after shareholder approval, at an initial conversion price equal to stated value. \* Unregistered offering under Securities Act exemptions; proceeds earmarked for working capital, general corporate purposes. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DNA X Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-031675), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [SONM.US](https://longbridge.com/en/quote/SONM.US.md)

## Related News & Research

- [DNA X amends 8-K to update disclosure on Series B preferred stock sale and note conversion](https://longbridge.com/en/news/292237487.md)
- [DNA: Q2 2026 revenue dropped 48% year-over-year, with major autonomous lab contracts secured](https://longbridge.com/en/news/295007946.md)
- [Lucid Diagnostics wins Concert coverage policy for EsoGuard esophageal DNA test across client health plans](https://longbridge.com/en/news/294970219.md)
- [Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test | LUCD Stock News](https://longbridge.com/en/news/294970708.md)
- [Another tough quarter for Fiserv may lead to product changes](https://longbridge.com/en/news/295271718.md)